Events & conferences in the Life Sciences industry
Below you find a list of upcoming events in the Life Sciences industry. We will be attending all events which are flagged with the Biotechgate / Venture Valuation logo.
If you are participating the conference and want to learn more, please contact us to schedule a meeting ››
The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare.
Product & Company Valuation Course
The Product & Company Valuation course is designed to teach a systematic approach to producing a valuation that can be used in investment rounds, mergers/acquisitions, licensing deals, or strategic development decisions in the pharma-biotech world. This introductory course is very valuable for pharma and biotech executives who are not familiar with compound and company valuations but need a thorough understanding of the valuation concepts and techniques that are commonly applied in the pharma and biotech industries. It goes beyond the number-crunching techniques of most consultants and includes difficult to define qualitative factors which shape the risk profile of the company in question. This course optimally balances interactive lectures with practical group work exercises that are designed to help you practice the fundamental valuation tools & techniques taught throughout the day. Valuation is an inherently subjective task, which is made even more difficult in the life science industry due to its unique challenges: high attrition rates in R&D, long investment cycle, complex technologies, IP situations, etc. Therefore, traditional valuation methods are not suitable. Of particular value in this course is the “Product Valuation and Deal Structuring” module where registrants will learn the commonly used rNPV (i.e., risk-adjusted Net Present Value) method for calculating the value of a drug in development. Subsequently, you will practice how to structure a licensing deal between companies. Registrants will use an Excel-based tool designed specifically for this module, which can be taken home for future use.
Representatives from Venture Valuation and Biotechgate will participate in Product & Company Valuation Course
BIO International Convention 2022
The BIO International Convention attracts 15,000+ biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. We bring together a wide spectrum of life science and application, including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology, and cell therapy.
Representatives from Venture Valuation and Biotechgate will participate in BIO International Convention 2022
The Pharma Business Development Course with Stefan Fischer
Understand the structure of the pharma business development process in the pharma-biotech world – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning... up to closing and following-up a deal
Bio-Manufacturing Innovation Summit
Piscataway United States
Driving meaningful innovation, impact and value creation in Bio-Manufacturing and ensuring resilient, adaptable supply chains, efficient re-shoring, on-shoring and cutting edge pharma manufacturing solutions to meet demand and accelerate the development and production of essential novel therapeutics and vaccines, in the US and globally. The Bio-Manufacturing Summit and partnering forum is co-organized by Broadreach Global and Host Partners Rutgers University, with support from NIIMBL - the National Institute for Innovation in Manufacturing Biopharmaceuticals, and our Global Innovation Partners MBHB LLC, Patent Docs, Mazards, and the Biotechgate Partnering Platform - HelloPartnering.
Representatives from Venture Valuation and Biotechgate will participate in Bio-Manufacturing Innovation Summit
ChinaBio® Partnering Forum 2022
ChinaBio® Partnering Forum is the largest and most productive China-focused life science partnering event. To be held as a hybrid event, September 13-16, the conference will bring together biotech and pharma leaders from around the world along with hundreds of China-based developers of novel technologies for two days of successful partnering.
Representatives from Venture Valuation and Biotechgate will participate in ChinaBio® Partnering Forum 2022
Pharma-Biotech Product & Company Valuation with Dr. P Frei
Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world – Know how to assess and calculate the value of a biotech company – Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal.
BioFuture is where relentless pioneers, innovators and entrepreneurs gather to assess the present and shape the future of healthcare and digital health. Participate in candid, unfiltered discussions and explore the exciting mashup between rapidly evolving fields including biopharma, digital medicine, big data, AI, healthcare systems, payors, and more. The coming decade will dramatically accelerate the transformation of the healthcare ecosystem. Be part of the discussions that will shape and transform the future of healthcare.
Representatives from Venture Valuation and Biotechgate will participate in BioFuture